Protease Nexin-1 and Breast Cancer
Author Information
Author(s): Candia Britny J, Hines William C, Heaphy Christopher M, Griffith Jeffrey K, Orlando Robert A
Primary Institution: University of New Mexico, School of Medicine
Hypothesis
Does Protease Nexin-1 (PN-1) contribute to the regulation of uPA and participate in the development of a metastatic phenotype in human breast cancers?
Conclusion
PN-1 expression is elevated in human breast cancer and correlates with increased levels of PAI-1 and uPA, suggesting it may contribute to tumor cell motility and metastasis.
Supporting Evidence
- PN-1 expression was elevated in 21 of 26 human breast tumors examined.
- PAI-1 and uPA mRNA levels were significantly higher in 19 and 22 of 26 tumors, respectively.
- MDA-MB-231 cells expressed 3.5-fold greater levels of PN-1 than MCF-7 cells.
Takeaway
This study found that a protein called PN-1 is more active in breast cancer tissues than in normal tissues, which might help cancer cells move and spread.
Methodology
Quantitative real-time PCR was used to measure PN-1, PAI-1, and uPA expression levels in breast tumor and normal tissue samples.
Limitations
The study primarily examined advanced stage, grade 2 and 3 breast cancers, limiting the ability to correlate PN-1 expression with tumor grade or patient outcomes.
Participant Demographics
26 breast tumor samples from anonymous patients and 10 normal breast tissue samples from female patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website